https://www.mithra.com/wp-content/uploads/2018/12/ring-1030x1030.jpg 1030 1030 Mithra Pharmaceuticals https://www.mithra.com/wp-content/uploads/2017/05/logo-mithra-women-s-health.png Mithra Pharmaceuticals2019-11-08 07:30:542020-07-03 11:50:16European Authorities Approve Advantageous Modifications to Myring™ labelling
- Removal of requirement for special temperature storage for vaginal contraceptive ring Myring™
- Competitive advantage in terms of reduced costs and convenience for distributors, pharmacists and patients
- Similar labelling to be pursued in the United States
Liege, Belgium, 08 November 2019 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces that the European Authorities has approved two noteworthy modifications relating to the change in the shelf-life and storage conditions of its vaginal contraceptive ring Myring™.